查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
第一代细胞的全球市场 - 规模，占有率，趋势分析，机会，预测:来源，各类型，各终端用户，各地区(2019年～2029年)
市场调查报告书
商品编码
1249977

第一代细胞的全球市场 - 规模，占有率，趋势分析，机会，预测:来源，各类型，各终端用户，各地区(2019年～2029年)

Primary Cells Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Origin ; By Type ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球第一代细胞的市场规模，从2022年的42亿9,000万美元到2029年预计达到86亿美元，在2023年～2029年的预测期间内11.6％的年复合成长率大幅度成长。市场主要成长要素，是癌症的发生率增加，癌症研究的政府辅助扩大，支撑医疗产业的基础设施扩大等。

本报告提供全球第一代细胞市场相关相关分析，提供市场规模与预测，市场区隔分析，地区分析，企业简介等资讯。

目录

第1章 调查架构

第2章 摘要整理

第3章 全球第一代细胞市场考察

  • 产业价值链分析
  • DROC分析
    • 促进因素
    • 阻碍因素
    • 机会
    • 课题
  • 技术的进步/最近的发展
  • 法律规范
  • 波特的五力分析

第4章 全球第一代细胞市场概要

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
      • 人第一代细胞
      • 动物第一代细胞
    • 各类型
      • 造血细胞
      • 皮肤细胞
      • 消化管细胞
      • 肝细胞
      • 其他(肺细胞，肾细胞，心臟细胞，肌肉骨骼细胞，第一代细胞)
    • 各终端用户
      • 生命科学研究企业
      • 研究机关
    • 各地区
      • 北美
      • 欧洲
      • 亚太地区
      • 南美
      • 中东、非洲

第5章 北美的第一代细胞市场

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
    • 各类型
    • 各终端用户
    • 各国
      • 美国
      • 加拿大

第6章 欧洲的第一代细胞市场

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
    • 各类型
    • 各终端用户
    • 各国
      • 德国
      • 英国
      • 义大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他的欧洲

第7章 亚太地区的第一代细胞市场

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
    • 各类型
    • 各终端用户
    • 各国
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲、纽西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 其他的亚太地区

第8章 南美的第一代细胞市场

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
    • 各类型
    • 各终端用户
    • 各国
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 其他的南美

第9章 中东、非洲的第一代细胞市场

  • 市场规模与预测(2019年～2029年)
    • 金额
  • 市场占有率与预测
    • 各来源
    • 各类型
    • 各终端用户
    • 各国
      • 沙乌地阿拉伯
      • 阿拉伯联合大公国
      • 卡达
      • 科威特
      • 南非
      • 奈及利亚
      • 阿尔及利亚
      • 其他的中东、非洲

第10章 竞争情形

  • 主要企业与其产品的清单
  • 全球第一代细胞企业的市场占有率分析(2022年)
  • 竞争基准:各经营参数
  • 主要策略的展开(合併，收购，伙伴关係等)

第11章 COVID-19对全球第一代细胞市场的影响

第12章 企业简介(企业概要，财务矩阵，竞争情形，主要的人力资源，主要的竞争，联络处，策略性预测，SWOT分析)

  • Thermo Fisher Scientific Inc
  • Merck Group
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell-Human Centered Science
  • ZenBio, Inc.
  • STEMCELL Technologies Inc
  • AllCells
  • 其他的着名企业

第13章 主要策略的推荐事项

第14章 调查手法

简介目录
Product Code: BWC23223

Global Primary Cells Market Size Doubles to Reach USD 8.6 Billion by 2029.

Global primary cells market is flourishing because of increasing adoption of technology advancements and growing cancer research and development.

BlueWeave Consulting, a leading strategic consulting and Market research firm, in its recent study, estimated global primary cells market size at USD 4.29 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global primary cells market size to grow at a significant CAGR of 11.6% reaching a value of USD 8.6 billion by 2029. Major growth factors of global primary cells market include an increasing incidence of cancer, growing government support for cancer research, and expanding infrastructure to support the healthcare industry. The growing prevalence of chronic diseases worldwide, such as cancer, infections, autoimmune disorders, diabetes, and cardiovascular diseases, is a significant contributor to the growth of the primary cell market. It has also led to a rise in research activities for advanced therapies. The use of primary cell cultures for drug screening and in-vitro testing is also becoming increasingly popular, contributing to the growth of the primary cell market. The global primary cells market is being driven by advancements in genetic engineering and increased funding for research into cellular treatments. However, concerns regarding primary cell culture contamination are anticipated to restrain the overall market growth during the period in analysis.

Global Primary Cells Market - Overview:

The primary cells market refers to the market for primary cells, which are cells that have been freshly isolated from living tissues or organs, typically from humans or animals. These cells are used for research purposes, including drug discovery and development, toxicology testing, and basic research. Primary cells are important tools for studying biological processes and diseases, and they are widely used in both academic and commercial research settings. The primary cells market includes the production, distribution, and sale of primary cells, as well as related products and services such as cell culture media, reagents, and cell isolation kits.

Impact of COVID-19 on Global Primary Cells Market

COVID-19 had a positive impact on primary cell market. Primary cell culture is being used by researchers to better understand the infection and build standardized epithelial cell culture models. These models can assist duplicate the features of the respiratory tract, perhaps leading to breakthrough scientific findings with medical applications. In addition, the identification of primary cells for the treatment of many diseases is expanding. Due to their increased use in a variety of healthcare applications, private associations, biotech businesses, and government agencies have increased their interest and investment in this area. The growing utilization of primary cell cultures for viral synthesis, which is then used to make numerous vaccines, is also projected to move the market ahead.

Global Primary Cells Market - By Region:

Global primary cells market covers five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest share of revenue in the primary cell culture market and this trend is expected to continue throughout the forecast period. The growth in the region's market can be attributed to factors such as the high cost of healthcare, the increasing elderly population, the rising prevalence of chronic illnesses, and government funding support. Furthermore, the market in the region is expanding due to the focus of market players on developing innovative cell culture applications, improved instrumentation, a wide range of cell types, and the study of their cellular interactions.

Competitive Landscape

Major players operating in global primary cells market include Thermo Fisher Scientific Inc, Merck Group, Lonza, Cell Biologics, Inc., PromoCell - Human Centered Science, ZenBio, Inc., STEMCELL Technologies Inc, and AllCells. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Primary Cells Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Primary Cells Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Primary Cells Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Cancer Research
      • 3.2.1.2. Advancement in Technologies
    • 3.2.2. Restraints
      • 3.2.2.1. Concern Regarding Primary Cell Culture Contamination
    • 3.2.3. Opportunities
      • 3.2.3.1. Advancing Biomedical Research Using Primary Cells in 3D Cultures
    • 3.2.4. Challenges
      • 3.2.4.1. Impact on Supply Chain Due to Covid
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Primary Cells Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Origin
      • 4.2.1.1. Human Primary Cells
      • 4.2.1.2. Animal Primary Cells
    • 4.2.2. By Type
      • 4.2.2.1. Hematopoietic Cells
      • 4.2.2.2. Dermatocytes
      • 4.2.2.3. Gastrointestinal Cells
      • 4.2.2.4. Hepatocytes
      • 4.2.2.4.1. Cryopreserved Hepatocytes
      • 4.2.2.4.2. Fresh Hepatocytes
      • 4.2.2.5. Others (Lung Cells, Renal Cells, Heat Cells, Musculoskeletal Cells, Primary Cells)
    • 4.2.3. By End User
      • 4.2.3.1. Life Science Research Companies
      • 4.2.3.2. Research Institutes
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Primary Cells Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Origin
    • 5.2.2. By Type
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Origin
      • 5.2.4.1.2. By Type
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Origin
      • 5.2.4.2.2. By Type
      • 5.2.4.2.3. By End User

6. Europe Primary Cells Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Origin
    • 6.2.2. By Type
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Origin
      • 6.2.4.1.2. By Type
      • 6.2.4.1.3. By End User
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Origin
      • 6.2.4.2.2. By Type
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Origin
      • 6.2.4.3.2. By Type
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By Origin
      • 6.2.4.4.2. By Type
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Origin
      • 6.2.4.5.2. By Type
      • 6.2.4.5.3. By End User
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Origin
      • 6.2.4.6.2. By Type
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Origin
      • 6.2.4.7.2. By Type
      • 6.2.4.7.3. By End User
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Origin
      • 6.2.4.8.2. By Type
      • 6.2.4.8.3. By End User
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Origin
      • 6.2.4.9.2. By Type
      • 6.2.4.9.3. By End User

7. Asia-Pacific Primary Cells Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Origin
    • 7.2.2. By Type
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Origin
      • 7.2.4.1.2. By Type
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By Origin
      • 7.2.4.2.2. By Type
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Origin
      • 7.2.4.3.2. By Type
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Origin
      • 7.2.4.4.2. By Type
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Origin
      • 7.2.4.5.2. By Type
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Origin
      • 7.2.4.6.2. By Type
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Origin
      • 7.2.4.7.2. By Type
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Origin
      • 7.2.4.8.2. By Type
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Origin
      • 7.2.4.9.2. By Type
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Origin
      • 7.2.4.10.2. By Type
      • 7.2.4.10.3. By End User

8. Latin America Primary Cells Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Origin
    • 8.2.2. By Type
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Origin
      • 8.2.4.1.2. By Type
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Origin
      • 8.2.4.2.2. By Type
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Origin
      • 8.2.4.3.2. By Type
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Origin
      • 8.2.4.4.2. By Type
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Origin
      • 8.2.4.5.2. By Type
      • 8.2.4.5.3. By End User

9. Middle East & Africa Primary Cells Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Origin
    • 9.2.2. By Type
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Origin
      • 9.2.4.1.2. By Type
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Origin
      • 9.2.4.2.2. By Type
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Origin
      • 9.2.4.3.2. By Type
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Origin
      • 9.2.4.4.2. By Type
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Origin
      • 9.2.4.5.2. By Type
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Origin
      • 9.2.4.6.2. By Type
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Origin
      • 9.2.4.7.2. By Type
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Origin
      • 9.2.4.8.2. By Type
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Primary Cells Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Primary Cells Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc
  • 12.2. Merck Group
  • 12.3. Lonza
  • 12.4. Cell Biologics, Inc.
  • 12.5. PromoCell - Human Centered Science
  • 12.6. ZenBio, Inc.
  • 12.7. STEMCELL Technologies Inc
  • 12.8. AllCells
  • 12.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations